Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin PK in Healthy Middle-Aged Adults
NCT06434038Phase 1Withdrawn
- Sponsor
- HealthPartners Institute
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of human insulin in Mild Cognitive Impairment (MCI) and Dementia (3 arms), sponsored by HealthPartners Institute. Primary endpoints: Concentration of insulin over Time - Cerebrospinal fluid, Cmax of insulin concentration- Cerebrospinal Fluid and 2 more. Planned start Aug 2025; status: withdrawn.
02
Drugs
human insulin
03
Conditions
Mild Cognitive Impairment (MCI)Dementia
Beyond the preview
Go deeper on NCT06434038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06434038.